Queen Margaret University   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Musselburgh United Kingdom (1875)

Organization Overview

First Clinical Trial
2008
NCT00815451
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Angela Stockton | Queen Margaret University | Queen Margaret University, Nutrition and Biological Sciences, Musselburgh, Scotland, UK

Active Ingredients

Drugs in Phase 2 Trials (1)

dark chocolate (1 trial)

Drugs in Phase 1 Trials (1)

pomegranate extract (3 trials)

Drugs in Other Trials (6)

beta-glucans (1 trial)

cocoa bean (1 trial)

l-epigallocatechin (1 trial)

methylprednisolone (medrol) (1 trial)

oatmeal (1 trial)

vitamin d (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Obesity (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 10
  • # of Trial APIs: 8